MX2009012711A - Uso de 4-fenil-imidazol-2-tionas como inhibidores de la tirosinasa, para la preparacion de composiciones farmaceuticas o cosmeticas destinadas al tratamiento o la prevencion de trastornos pigmentarios. - Google Patents

Uso de 4-fenil-imidazol-2-tionas como inhibidores de la tirosinasa, para la preparacion de composiciones farmaceuticas o cosmeticas destinadas al tratamiento o la prevencion de trastornos pigmentarios.

Info

Publication number
MX2009012711A
MX2009012711A MX2009012711A MX2009012711A MX2009012711A MX 2009012711 A MX2009012711 A MX 2009012711A MX 2009012711 A MX2009012711 A MX 2009012711A MX 2009012711 A MX2009012711 A MX 2009012711A MX 2009012711 A MX2009012711 A MX 2009012711A
Authority
MX
Mexico
Prior art keywords
treating
cosmetic compositions
thiones
imidazole
phenyl
Prior art date
Application number
MX2009012711A
Other languages
English (en)
Inventor
Branislav Musicki
Jean-Guy Boiteau
Isabelle Pelisson
Itaru Suzuki
Marielle Berthier
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of MX2009012711A publication Critical patent/MX2009012711A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/42—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

La presente invención se refiere al uso de 4-fenil-imidazol-2-tion a como inhibidores de la tirosinasa, para la preparación de composiciones farmacéuticas o cosméticas destinadas al tratamiento o a la prevención de trastornos pigmentarios. La presente invención se refiere a la utilización de los compuestos de la fórmula general (I) siguiente para la preparación de composiciones farmacéuticas o cosméticas destinadas al tratamiento o a la prevención de trastornos pigmentarios.
MX2009012711A 2007-06-05 2008-06-04 Uso de 4-fenil-imidazol-2-tionas como inhibidores de la tirosinasa, para la preparacion de composiciones farmaceuticas o cosmeticas destinadas al tratamiento o la prevencion de trastornos pigmentarios. MX2009012711A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0755468A FR2916976B1 (fr) 2007-06-05 2007-06-05 Utilisation de 4-phenyl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, pour la preparation de composition pharmaceutiques ou cosmetiques destinees au traitement ou a la prevention des desordres pigmentaires.
PCT/FR2008/050993 WO2008152330A2 (fr) 2007-06-05 2008-06-04 Utilisation de 4-phenyl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, pour la préparation de compositions pharmaceutiques ou cosmétiques destinées au traitement ou à la prévention des désordres pigmentaires

Publications (1)

Publication Number Publication Date
MX2009012711A true MX2009012711A (es) 2009-12-08

Family

ID=38866280

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009012711A MX2009012711A (es) 2007-06-05 2008-06-04 Uso de 4-fenil-imidazol-2-tionas como inhibidores de la tirosinasa, para la preparacion de composiciones farmaceuticas o cosmeticas destinadas al tratamiento o la prevencion de trastornos pigmentarios.

Country Status (11)

Country Link
US (1) US20100160401A1 (es)
EP (1) EP2164486A2 (es)
JP (1) JP2010529095A (es)
KR (1) KR20100017632A (es)
CN (1) CN101678000A (es)
AU (1) AU2008263665A1 (es)
CA (1) CA2688234A1 (es)
FR (1) FR2916976B1 (es)
MX (1) MX2009012711A (es)
RU (1) RU2009148786A (es)
WO (1) WO2008152330A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013083645A2 (en) * 2011-12-07 2013-06-13 Unilever Plc Skin lightening composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4798843A (en) * 1987-07-09 1989-01-17 Smithkline Beckman Corporation 2-mercaproimidazole dopamine-β-hydroxylase inhibitors
JPH05124923A (ja) * 1991-04-09 1993-05-21 Sansho Seiyaku Co Ltd メラニン生成抑制外用剤
JPH05132422A (ja) * 1991-04-09 1993-05-28 Sansho Seiyaku Co Ltd メラニン生成抑制外用剤
FR2917087B1 (fr) * 2007-06-05 2012-09-21 Galderma Res & Dev Nouveaux 4-phenyl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique.

Also Published As

Publication number Publication date
JP2010529095A (ja) 2010-08-26
KR20100017632A (ko) 2010-02-16
EP2164486A2 (fr) 2010-03-24
WO2008152330A2 (fr) 2008-12-18
WO2008152330A3 (fr) 2009-02-26
FR2916976B1 (fr) 2009-09-04
FR2916976A1 (fr) 2008-12-12
RU2009148786A (ru) 2011-07-20
CN101678000A (zh) 2010-03-24
AU2008263665A1 (en) 2008-12-18
CA2688234A1 (fr) 2008-12-18
US20100160401A1 (en) 2010-06-24

Similar Documents

Publication Publication Date Title
MX2012007098A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
MX2020012825A (es) Compuestos multiciclicos y metodos de uso de los mismos.
MX2012007161A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
MY149512A (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
GEP20135785B (en) Pyrrolopyrimidine compounds as cdk inhibitors
TN2014000016A1 (en) 4 - piperidinyl compounds for use as tankyrase inhibitors
MX2011007750A (es) Composiciones y metodos para inhibicion de la ruta jak.
TNSN08370A1 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
JO2892B1 (en) CYP inhibitors 17
MX2011011661A (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750.
WO2009118107A3 (de) Hautpflege-zusammensetzung
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
EA201101341A1 (ru) Соединения, ингибирующие киназы, и фармацевтическая композиция на их основе
GEP20146146B (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
MX2013004329A (es) 6-amino-nicotinamidas sustituidas como moduladores de kcnq2/3.
IN2012DN01233A (es)
MY148948A (en) Catecholamine derivatives and prodrugs thereof
TN2011000291A1 (en) Purine compounds
MX2020009397A (es) Composiciones y metodos para inhibicion de la via jak.
JO3007B1 (ar) مركبات و تركيبات كمثبطات كيناز بروتين
MY167898A (en) Co-crystals and salts of ccr3-inhibitors
MX2012001134A (es) Composiciones y metodos para inhibicion de la via jak.
WO2010150211A3 (en) Use of derivatives of indoles for the treatment of cancer
EA201001586A1 (ru) Соединения и композиции в качестве ингибиторов itpkb
MX342119B (es) 2-oxi-quinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.

Legal Events

Date Code Title Description
FG Grant or registration